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Antibody responses  to soluble  polysaccharides, such as  streptococcus A  carbohy- 
drate,  levan, galactan, and dextran are often of very limited heterogeneity, and the 
capacity to produce a given form of these anti-polysaccharide antibodies is frequently 
determined by genes that map to the Igh-V region of the Igh gene complex (1-5). The 
actual  repertoire  of antibodies  that  potentially  can  be  produced  in  response  to 
immunization with such polysaccharide antigens is, however, very much greater, as 
revealed by the appearance of new clonotypes in mice previously suppressed by anti- 
idiotype antibody or in mice that have been immunized with polysaccharide-protein 
complexes  or  with  polysaccharide-containing  microorganisms.  Relatively  little  is 
known  about  the  genetic or cellular  events  that  determine  which  of the  potential 
antibodies that an animal is capable of synthesizing in response to a  given antigen is 
actually produced. 
In this communication, we report a study of the genetic regulation of the isoelectric 
focusing (IEF) 1 pattern  of the IgG antibody produced in  response to immunization 
with a soluble polysaccharide, bacterial levan (BL). BL is a fl-(2 ~  6) polyfructosan 
with fl-(2 ~  1) branch points. BALB/c mice immunized with BL produce antibodies 
that bind inulin (In), a fl-(2 --* 1) polyfructosan, as well as antibodies that are specific 
for the fl-(2 ~  6) levan determinants. The anti-In antibodies express a family of cross- 
reactive  idiotypes  (IdX)  that  are  also  found  on  a  series  of  BALB/c  In-binding 
myeloma proteins.  In contrast, C57BL/6 and C.B20 strains,  the latter of which is a 
BALB/c congenic strain  that  possesses  an Igh  complex of b (C57BL/6)  type, fail  to 
produce significant levels  of anti-In antibody or of IdX upon BL immunization. 
We have examined the regulation of IgG anti-In antibodies by comparing the IEF 
patterns  of anti-In antibodies  of BALB/c mice  and  those of B.C8  mice, which are 
congenic to  C57BL/Ka  and  possess  the  Igh a  complex of BALB/c, of (BALB/c  × 
C57BL/6)F1 mice, and of the (BALB/c ×  C57BL/6) recombinant inbred  (RI) lines, 
CXBG  and  CXBJ,  both  of which  are  Igh"  homozygous.  Our  results  show  that 
although the production of IgG anti-In requires genes that are found in the a (BALB/ 
J Abbreviations used in this paper: Bis, N,N'-methylene-bis-acrylamide;  BL, bacterial levan; BSA, bovine 
serum albumin; CFA, complete Freund's adjuvant; DATD, N,N'-diallyltartardiamide: HA, hemaggluti- 
nation analysis; IdX, cross-reactive idiotype(s); IEF, isoelectric focusing; In, inulin: In-BA, In coupled to 
Brucella abortus; In-KLH, In coupled to keyhole limpet hemocyanin; KLII, keyhole limpet hemocyanin; 
methacrylsilane, 3-methacryloxypropyltrimethoxysilane; MHC,  major histocompatibility complex; RI, 
recombinant inbred; Sr-l, spectrotype regulation gene 1; TEMED, N,N,N',N'-tetramethylethylenediamine. 
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TABLE  I 
H-2 and Ig Haplotypes of Mice Used in These Studies 
Strain  H-2  Igh 
BALB/e AnN  d  a 
C57BL/6N  b  b 
B.C8  b  a 
C.B20  d  b 
CXBG  b  a 
CXBJ  b  a 
CXBI  b  b 
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c) type of the Igh gene complex, the complexity of the IEF pattern is regulated by at 
least one C57BL gene. This regulatory gene, here designated as spectrotype regulation 
gene 1 (Sr-1), is not linked to either the Igh gene complex, the major histocompatibility 
complex (MHC), or to the genes that control coat color. 
Materials and Methods 
Mice.  The strains used in these studies are listed in Table I, which indicates their MHC 
types and Igh types. They were obtained from the Small Animal Section, Division of Research 
Services, National Institutes of Health (NIH) (Bethesda, Md.) or The Jackson Laboratory (Bar 
Harbor, Maine), or were the kind gift of Dr. Michael Potter, NIH. F1 hybrids were bred in the 
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH. 
Antigens.  BL  (2  ×  107 daltons), from Aerobacter levanicum (ATCC  1,552), was obtained as 
previously described (6). In coupled to Brucella abortus (In-BA) and In coupled to keyhole limpet 
hemocyanin (KLH) (In-KLH) were prepared as described by Chien et al.  (7). 
Immunization of Mice.  Adult mice (8-12 wk of age) were immunized intravenously with 10- 
50/tg of BL in saline and were bled 5,  10, 20, 40, and 60 d after immunization. Other mice 
were immunized with 0.1  ml of a  1% suspension of In-BA, emulsified in complete Freund's 
adjuvant (CFA)  (Difco  Laboratories, Detroit, Mich.), and bled  10 d  later. Mice immunized 
with  In-KLH or  KLH  were  given  100 /~g of antigen in CFA,  intraperitoneally, and were 
boosted at 2 and 3 wk with 50/lg of antigen in incomplete Freund's adjuvant. They were bled 
1 wk after the last injection. 
Determination of Immunoglobulin Allotypes.  Allotype analysis was  performed as described by 
Lieberman (8). 
Determination of H-2 Types.  H-2 typing was performed by a modification of the microcyto- 
toxicity method  described by Sachs et  al.  (9). Typing was  performed on peripheral blood 
lymphocytes isolated by Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, 
N. J.)-Hypaque (Winthrop Laboratories, New York)  centrifugation (D. Sachs.  Personal com- 
munication.) with anti-H-2  d and H-2  b sera provided by Dr.  David Sachs,  National Cancer 
Institute, NIH. 
IEF.  IEF was performed by a  modification of the method described by Briles and Davie 
(10) and refined by Nicolotti et al. (11). 3-Methacryloxypropyltrimethoxysilane  (methacrylsi- 
lane) and N,N'-diallyltartardiamide  (DATD) were purchased from Polysciences,  Inc., Warring- 
ton, Pa. Acrylamide, N,N'-methylene-bis-acrylamide  (Bis), and N,N,N',N'-tetramethylethylene- 
diamine (TEMED) were purchased from Bio-Rad Laboratories, Richmond, Calif. Riboflavin, 
taurine, and lysine (free base)  were purchased from Sigma Chemical Co., St. Louis, Mo., and 
ampholines were purchased from LKB Instruments, Inc., Rockville, Md. Ultrapure urea was 
purchased from BRL, Inc., Rockville, Md., and stock solutions were deionized on a mixed-bed 
ion-exchange resin column of Amberlite, MB-3 (Mallinckrodt Inc., St.  Louis, Mo.).  Glutaral- 
dehyde was purchased from Eastman Kodak Co.,  Rochester, N. Y. 
A 10- ×  15-cm gel (0.6-ram thick) was cast in a vertical apparatus (10) between a plexiglass 
backing plate and a glass plate that had been previously treated with methacrylsilane (11) to 
produce covalent attachment of the acrylamide gel to the glass surface.  The gel solution was 
prepared from the following components: 5.1  ml DATD-acrylamide (3%  [wt/vol] DATD + 1090  REGULATION  OF ANTIBODY EXPRESSION 
17% [wt/vol] acrylamide); 7.75 ml 8 M urea; 5.1 g glycerol; 0.7 ml pH 5-8 ampholines; 0.4 ml 
pH 8-9.5 ampholines (the mixture was degassed  for  1-2 min before adding catalysts);  1 ml 
riboflavin (4 mg/100 ml); 100 ~1 TEMED (20%); and 100/~1 ammonium persulfate (1%). The 
gel mixture was immediately poured into a 20-ml syringe and was applied between the plates 
of the apparatus with a 22-g (1.5-in.) needle. A 2- ×  15-cm Bis gel overlay, into which a Teflon 
(E. I. DuPont de Nemours & Co., Inc., Wilmington, Del.) comb that contained 20 sample slots 
was  imbedded during polymerization, was  immediately applied over the DATD-acrylamide 
mixture with a 3-ml syringe that was fitted with a 22-g needle. The Bis gel was prepared from 
the following mixture: 1.2 ml 8 M urea; 0.49 ml Bis (33% acrylamide [wt/vol] + 0.81% Bis [wt/ 
vol]);  1.05 ml H20;  0.16  p~l  pH  5-8 ampholines (the mixture was degassed  for  30  s before 
adding the  catalysts);  156 #1  riboflavin (4  mg/100 ml);  15.6 #1  TEMED  (20%); and  1 ~1 
ammonium persulfate. The gels were polymerized for 3 h at room temperature under fluorescent 
illumination. The Teflon comb was  removed from the gel  and any unpolymerized gel  was 
aspirated from the sample slots. Serum (10/~1) was mixed with 10 #1 8 M urea and loaded into 
the sample slots. Samples were then overlaid with ~5 #1  1 M urea that contained 3% pH 3.5- 
5 ampholines. Gels were  run at 2 mA at constant current for  14-15 h  at 4°C. The positive 
electrode compartment (top)  was  filled with 0.1  M  taurine, which contained five  drops  of 
phosphoric acid per liter, and the negative electrode compartment (bottom) was filled with 0.1 
M lysine (fg'ee base), which contained 2 ml of ethanolamine per liter. After completion of IEF, 
the gels were rinsed briefly under running distilled water, and the pH was measured over the 
entire length of the gel with a flat-bed electrode. Immunoglobulins  were precipitated by three 
changes of 18% Na2SO4 over a period of 6 h. The gels were overlaid for 24 h with 15-20 ×  106 
cpm/gel (or 7-10 ×  106 cpm/half gel) of 125I-labeled antigen that was diluted in 18% Na2SO4 
that contained 1% bovine serum albumin (BSA). After exposure to labeled antigen, the gels 
were washed for 24 h with at least three changes of 18% Na2SO4 and were fixed for 30 min in 
18% Na2SO4 that contained 0.5% glutaraldehyde. After fixation, the gels were washed overnight 
in phosphate-buffered saline (0.02 M  PO4  and 0.15  M  NaCI,  pH  7.4), followed  by 6  h  in 
distilled water (three changes), and finally for  1 h  in 40% ethanol. The gels were then dried 
(either overnight in air or for 30 min at  100°C)  and exposed  to x-ray film. Either Kodak single 
emulsion SB-5 or double emulsion XR5 film was used. Films were exposed  for 7 d. When XR5 
film was used, the emulsion on the side of the film not exposed  directly to the gel was removed 
after development of the film by gently rubbing off the emulsion with gauze soaked  in a 5.25% 
solution of NaCIO (commerical laundry bleach) followed by rinsing under running tap water. 
Iodinated Antigens.  In-BSA was prepared by the method of Chien et al. (7) and iodinated by 
the chloramine T method (12) to a 30/~Ci//~g sp act. Levan was tyraminated by the method of 
Keck (13) and iodinated by the chloramine T  method to a  10/~Ci/p.g sp act. Labeled antigens 
were stored at -20°C and used for 4-6 wk. 
Results 
IEF Pattern of Antibodies Produced by BALB/c Mice Immunized with BL.  BALB/c mice 
immunized  with  BL  produce  antibodies  that  react  with  BL  and  cross-reacting 
antibodies that  bind In. The  anti-In antibodies bear  the  IdX  found on  many In- 
binding myeloma proteins (4). These BALB/c anti-In antibodies display a character- 
istic IEF pattern (Fig.  1)  that is essentially identical in all individuals, although  1 of 
the  18 mice shown in Fig.  1 failed to respond to BL. This pattern consists of a  single 
spectrotype comprised of five bands, of which three predominate, and which focus on 
IEF gels in the pH 6.3-6.8 range (Fig.  1). The anti-BL antibodies from the same  18 
individuals are shown in the lower half of Fig. 1. As can be seen, the anti-In antibodies 
react  with  BL,  although  weakly,  probably  a  result  of  the  paucity  of fl-(2  ~  1) 
determinants in BL.  Most  individuals produced IgG anti-BL in addition to anti-In, 
and these antibodies are specific for the fi-(2 ---* 6)  levan determinant because they do 
not cross-react with In. Unlike the IEF pattern of anti-In antibodies, which is shared 
by all individual BALB/c mice, the anti-BL antibodies of these  18 individuals consist STEIN,  BONA, LIEBERMAN, CHIEN,  AND  PAUL  1091 
Fio.  1.  IEF pattern  of BALB/c anti-BL antibodies. Sera obtained from 18 individual BALB/c 
mice at 10 d after immunization with BL were focused in duplicate gels in the same sample slot in 
both gels. The upper panel shows the antibodies reactive with 125I-In-BSA,  and the lower panel 
shows the antibodies reactive with 125I-BL. 
of at  least  five  distinct  sets  of bands,  each  of which  may  be  considered  to  be  a 
spectrotype.  Moreover, individual sera exhibit different combinations of these spec- 
trotypes. The levan-specific antibodies focus between pH 7 and 8.5 and are thus quite 
distinct from the anti-In antibodies. Neither the anti-In nor the anti-BL spectrotypes 
change over a  period of 40 d  after immunization (Fig. 2). 
To investigate whether the anti-In spectrotype represented the entire clonal reper- 
toire of IgG anti-In antibodies of BALB/c mice, other BALB/c mice were immunized 
with In coupled to various carriers such as KLH and B. abortus. Immunizations with 
In-BA and In-KLH were performed in CFA. The IEF pattern of anti-In antibodies 
elicited by In-BA is considerably more heterogeneous than that elicited by BL  (Fig. 1092  REGULATION OF ANTIBODY  EXPRESSION 
FIG.  2.  IEF pattern  of BALB/c anti-BL antibodies at  various times after  immunization.  Sera 
obtained from two representative individual BALB/c mice at 5, 10, 20, and 40 d after immunization 
with BL were focused in duplicate in the same gel. The gel was cut and one-half was exposed to ~5I- 
In-BSA (left panel) and the other to 125I-BL  (right panel). 
3). The IEF pattern of antibodies elicited by In-KLH shows even greater complexity 
(Fig.  3).  We  conclude  from  these  data  that  BALB/c  mice  possess  an  extensive 
repertoire  of anti-In antibodies  that,  nevertheless,  is not fully expressed  after immu- 
nization with soluble BL. 
IEF Pattern of Antibodies Produced by C57BL/6 Mice Immunized with BL.  In contrast 
to BALB/c mice, C57BL/6 mice immunized with BL produce high titers of anti-BL 
antibodies by hemagglutination analysis (HA) but only little or no hemagglutinating 
anti-In antibodies.  They also fail to produce the IdX characteristic of BALB/c mice 
(4).  Examination  of such  antisera  by  IEF  shows  that  C57BL/6  mice  produce  IgG 
anti-BL antibodies but no IgG anti-In antibodies  (Fig. 4). The population of C57BL/ 
6  mice  expresses  two  principal  anti-BL  spectrotypes.  An  occasional  mouse  (Fig.  4, 
animal 9) produces a  more complex pattern  that appears to consist of the antibodies 
present  in both of the index spectrotypes. 
IEF  Pattern  of  Antibodies Produced by  (BALB/c  X  C57BL/6)F1  and  Backcross 
Mice.  (BALB/c  ×  C57BL/6)FI  hybrid  mice  were  immunized  with  BL,  and  all 
developed  a  vigorous IdX-positive anti-In  antibody response.  IEF analysis  revealed 
that the pattern of their IgG anti-In antibodies was considerably more heterogeneous 
than that of anti-In antibodies produced by BALB/c mice in response to BL (Fig. 5). 
The increased heterogeneity of the F1 response is almost certainly not a  result of the 
expression of a latent anti-In response of the Igh b  type, because B.C8 anti-In antibodies 
express a  degree of antibody heterogeneity equivalent  to, or greater than, that of the 
F1 anti-In  antibodies  (Fig.  6).  B.C8  mice are Igh%homozygous  mice that  derive  the 
remainder  of their  genome  from  C57BL/Ka.  Thus,  a  gene  or  genes  of the  C57BL STEIN,  BONA,  LIEBERMAN,  CHIEN, AND PAUL  1093 
FIG.  3.  IEF pattern  of BALB/c anti-In  antibodies raised against In conjugates. The anti-ln-BA 
serum is a pool prepared from the sera obtained from three BALB/c mice at 10 d after immunization 
with In-BA. The preimmune and anti-KLH sera were from pools prepared from sera obtained from 
10 BALB/c mice before immunization or 10 d after immunization with KLH.  Anti-In-KLH  sera 
were obtained from five  individual BALB/c mice 1 wk after the third immunization with In-KLH. 
Sera were focused, and the gel was exposed to 12sI-In-BSA. 
mouse can lead to increases in the amount of diversity of the lgh a anti-In antibodies 
that are produced in response to immunization with BL. 
Backcross Analysis of the Anti-ln Response.  To estimate the number of C57BL/6 genes 
involved  in  this  regulation  of  lgha-determined  antibody  expression,  the  anti-In 
antibody  response  to  BL of (BALB/C  ×  C57BL/6)  ×  BALB/c backcross  mice was 
examined  (Fig.  7).  Of 25  such  progeny,  10  made antibody responses comparable to 
those of BALB/c mice and  15 displayed more heterogeneous responses. This suggests 
that one C57BL6 gene plays a dominant role in regulating the expression oflgh ~ anti- 
In  antibodies.  We  found  that  BALB/c-like  and  non-BALB/c-like responses  were 
essentially equally distributed among mice that were homozygous for the a  allotypic 
form of Ig H-chain  constant  regions  (lgh-C)  and  those  that  were a/b  heterozygotes 1094  REGULATION  OF ANTIBODY EXPRESSION 
FIG. 4.  IEF pattern of C57BL/6 anti-BL antibodies. Sera obtained from 10 individual C57BL/6 
mice at 10 d after immunization with BL were focused in duplicate in the same gel. The gel was cut 
and one-half was exposed to I2~I-In-BSA  (left panel) and the other half to 12~I-BL (right panel). The 
bands seen on the left half of the gel (In overlay) are bands that we consider to represent nonspecific 
binding  because the identical pattern can be seen with sera from unimmunized mice, as well as with 
immune sera, and with virtually any iodinated antigen that we have examined. No effort has been 
made to eliminate these bands as they serve as a useful internal marker. 
(Table  II).  Similarly, no  linkage of  the  IEF  pattern  of anti-In antibodies to  the 
presence of the b MHC haplotype was noted (Table II). Both patterns were found in 
both males and females and in mice of the three distinct coat colors found among the 
backcross progeny (Table II). Thus, the C57BL/6 gene that was involved in regulating 
the Igh a anti-In response appears not to be linked to the Igh complex, to the MHC, or 
to the genes specifying coat color. As noted earlier (Introduction), we define this gene 
as Sr-1.  The equal sex distribution is not informative for X  chromosomal linkage of 
Sr-1  because the  (BALB/c X  C57BL/6)F1 was the mother of the backcross progeny 
and thus transmitted a  C57BL/6 X  chromosome to one-half of both the  male and 
female offspring. 
IEF Patterns of Antibodies of Rl Mice Immunized with BL.  To further investigate the 
contribution of C57BL genes to the regulation of the anti-In antibody response, we 
studied the anti-In antibodies produced in response to BL immunization in CXB RI 
mice. These RI  lines were derived from separated  F2 lines of BALB/c  X  C57BL/6 
mice. Two such  lines possess  the a  haplotype of the Igh gene complex, CXBJ,  and 
CXBG;  both  produce IdX-positive anti-In antibodies after  immunization with  BL 
(14). In contrast, CXBI mice, which possess the b haplotype of the lgh-C gene complex, 
do not develop an IdX-positive anti-In response. The IEF patterns of anti-In antibod- 
ies  of these  strains  are  shown  in  Fig.  8.  CXBI  mice  fail  to  produce  IgG  anti-In 
antibodies. CXBJ mice produce anti-In antibodies with the spectrotype characteristic 
of that  of BALB/c  mice,  although  the  bands  are  of greater  intensity than  those STEIN, BONA, LIEBERMAN, CHIEN, AND PAUL  1095 
FIG. 5.  IEF  pattern  of (BALB/c ×  C57BL/6)Fl anti-BL antibodies. Sera obtained from 10 
individual (BALB/c × C57BL/6)FI mice at  l0 d after immunization with BL were focused and 
exposed to ~25I-In-BSA. 
observed in  BALB/c anti-BL  antisera.  CXBG mice produce  a  more heterogeneous 
pattern than do BALB/c. These data suggest that Sr-1, or some other C57BL/6 gene 
that  regulates  heterogeneity  of the  anti-In  response,  is  present  in  CXBG  but  not 
CXBJ mice. In further experiments, we tested this possibility by examining the anti- 
In antibodies produced in response to BL immunization of F1 hybrids of CXBJ and 
CXBG with BALB/c and C.B20 mice. 
IEF Patterns of Antibodies of FI Hybrids  Between RI Mice and BALB/c and C. B20 Mice 
Immunized  with BL.  Fa hybrids  from  (CXBI  X  BALB/c),  (CXBJ  ×  BALB/c),  and 
(CXBG X  BALB/c)  matings all develop IdX-positive anti-In antibodies in response 
to  BL  immunization  (data  not  shown).  The  IEF pattern  of (CXBG  ×  BALB/c)Fx 
anti-In antibodies resembles that of CXBG (Fig. 8), again supporting the conclusion 
that CXBG mice possess St-1 or another gene that regulates heterogeneity of anti-In 
antibodies.  Similarly, the finding that  (CXBI ×  BALB/c)F1  mice express an anti-In 
IEF pattern (Fig. 8) that is more complex than that of BALB/c indicates that CXBI, 
although  itself unable to produce anti-In antibodies, possesses an anti-In regulatory 
gene or genes.  Quite surprisingly,  the  (CXBJ  ×  BALB/c)F1  mice produced  anti-In 
antibodies  that  were  more complex than  either  parent  (Fig.  8).  This  suggests  that 
CXBJ does possess a  regulatory gene, although it is not expressed in the CXBJ itself. 
Certain of these regulatory effects also appear to be dependent upon homozygosity 
at the Igh gene complex. Thus, (CXBG ×  C.B20)F1 mice make an anti-In response to 1096  REGULATION OF ANTIBODY EXPRESSION 
FIG. 6.  IEF pattern of B.C8 anti-BL antibodies. Sera obtained from three individual B.C8 mice at 
various times (as indicated) before  or after immunization with BL were focusdd and exposed to a2sI- 
In-BSA. 
BL that resembles that of BALB/c mice rather than that of either CXBG or (CXBG 
×  BALB/c)F1 mice.  (CXBG  ×  C.B20)F1  and  (CXBG  ×  BALB/c)F1 should  differ 
only in that the former is heterozygous at the Igh gene complex, whereas the latter is 
homozygous.  This  effect  of Igh  gene  complex  heterozygosity  is  seen  even  more 
strikingly in (CXBJ ×  C.B20)Fx mice, which fail to produce an IdX-positive anti-In 
response to BL and lack IgG anti-In antibodies. This failure to produce IgG anti-In 
antibodies  has  been  observed  in  analysis  of three  separate  groups  of  (CXBJ  X 
C.B20)F1  mice  immunized on different  occasions. To confirm the  role of Igh  gene 
complex heterozygosity in the regulation of the anti-In response,  (CXBJ X C.B20)F2 
mice  were  bred  and  immunized  with  BL.  Among  11  mice  of this  type,  4  were 
homozygous for the a allotype. Analysis of the anti-In and anti-BL antibodies of eight 
of these  mice  by IEF  is  shown  in  Fig.  9.  Mice  1,  5,  7,  and  11  were  found  to  be 
homozygous for the a  haplotype of the Igh gene complex, whereas mice 2-4 and  10 
were found to be a/b heterozygous. One of the a allotype homozygous mice (No.  11) 
and  all  of the  a/b  heterozygous mice  produced  no  or  very  little  IgG  anti-In.  In 
contrast, one of the a/a homozygotes (No. 5)  produced a weak IgG response charac- 
teristic  of BALB/c mice,  whereas  the  two others  (1  and  7)  produced  IgG anti-In 
antibodies  substantially  more  heterogeneous  than  either  CXBJ  or  BALB/c.  This 
suggests that a  heterogeneous anti-In response to BL is favored by the presence of a 
C57BL background gene and by Igh a homozygosity. We should emphasize that Sr-1, ,
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TABLE  II 
Analysis  of Backcross Mice 
Trait 
Spectrotype 
Non-BALB/c 
BALB/c like  like 
Allotype  a/a  5  7 
a/b  5  7 
H-2 type  d/d  7  6 
b/d  2  5 
Sex  Male  4  6 
Female  6  9 
Coat color  Albino  3  9 
Agouti  3  2 
Brown  4  4 
as  defined  by  the  backcross  analysis,  is  expressed  in  both  Igh  homozygous  and 
heterozygous individuals.  This suggests that the regulatory gene observed in CXBG 
and  CXBJ  mice  may  be  different  from  Sr-1. In  contrast,  CXBI  mice  possess  a 
regulatory gene that functions in Igh heterozygous individuals and, thus, may be Sr- 
1. 
Discussion 
We  have  demonstrated  previously  (4,  14)  and  confirmed  in  this  study  that  the 
ability to produce IdX-positive anti-In antibodies in response to immunization with 
BL is linked to the a haplotype of the Igh gene complex. We have demonstrated here 
that this is also correlated with the presence of IgG anti-In antibodies, as demonstrated 
by IEF. The IEF data show that BALB/c mice develop a  very restricted IgG anti-In 
response  after immunization  with  BL.  This consists  of a  single  spectrotype that  is 
shared by all individuals and that does not change when examined at various intervals 
from 5 to 40 d  after immunization. Nonetheless, a dramatic increase in the heteroge- 
neity of the  response was  observed after immunization  with  In-BA in  CFA  or  In- 
KLH in CFA, which  indicates  that  the repertoire of anti-In antibodies  in  BALB/c 
mice is much greater than that normally expressed after immunization with BL. The 
increased heterogeneity was also observed after the introduction of at least one C57BL 
background  gene  (Sr-1) into  BALB/c mice. Indeed,  the spectrotypes of IgG anti-In 
antibodies in  (BALB/c ×  C57BL/6)F1  mice and in B.C8 mice are both significantly 
more heterogeneous than those of BALB/c anti-In antibodies. The Sr-I  gene that is 
expressed in F1 and B.C8 mice appears to be present in CXBI mice. The data suggest, 
furthermore, that other regulatory genes, the expression of which may differ in mice 
that are heterozygous for the a allotype, may exist. This is shown by the expression of 
a  strong IdX-positive anti-In response and a  heterogeneous IgG anti-In IEF pattern 
in  the  Fa  combination  of CXBG  crossed  to  BALB/c  mice.  In contrast,  (CXBG  × 
C.B20)F1  mice produce the spectrotype characteristic of BALB/c mice. 
The responsiveness of CXBJ mice is more difficult to interpret. The IEF pattern of 
anti-In antibodies  of CXBJ  mice is similar to BALB/c,  although  the  magnitude  is 
greater. When  F1 hybrids of (CXBJ  X  BALB/c)  were immunized with BL, the IEF 
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FIG. 8.  IEF  pattern of anti-BL antibodies of different strains of mice. Sera obtained from 
representative individual mice (at least 10 individuals of each strain and 4 of each FI combination 
were examined) of various strains at 5 or 10 d after immunization with BL were focused  and overlaid 
with 125I-In-BSA. 
either parent. This IEF regulatory effect, whether caused by St-1 or not, is also subject 
to  the  influence  of allotype heterozygosity. Thus,  (CXBJ  ×  C.B20)F1  mice  fail  to 
produce anti-In antibodies after immunization with BL. In addition, Igh heterozygous 
(CXBJ ×  C.B20)F2 mice made little or no IgG anti-In antibody, whereas two of four 
a allotype homozygous F2 mice produced heterogeneous IgG anti-In antibodies. These 
experiments strongly support the concept that the regulation of the anti-In response 
by certain C57BL genes is influenced by heterozygosity at the Igh gene complex. 
The findings presented here indicate that the expression of Igh-V structural  genes 
of anti-In antibodies is under the influence of nonallotype-linked background genes, 
such as Sr-1, which are present even in strains that lack the appropriate Igh-V genes 
themselves. Another example of this type of regulation is found in the response to BL 
of 129/Sv (Igh~), C57BL/6 (Ighb), and their RI lines.  The results of these studies also 
indicate the existence of a C57BL gene(s) that regulates spectrotype expression (K. E. 
Stein, C.  Bona, P.-A. Cazenave, J.-L. Gu~net, and W.  E.  Paul.  Unpublished obser- 
vations.). Other studies of the BL response in  (BALB/c ×  DBA/2)  (BXD)  RI lines 
and in AL/N and C.AL20 strains strongly suggest that such regulatory genes are not 1100  REGULATION OF ANTIBODY  EXPRESSION 
Fit?.. 9.  IEF pattern of anti-BL antibodies  of (CXBJ  X C.B20)F2 mice. Sera obtained from 8 
(CXBJ X C.B20)F2 mice at l0 d after immunization  with BL were focused in duplicate in the same 
gel. The gel was cut, and one-half was exposed to 12sI-In-BSA  (left panel) and the other half to 12~I- 
BL (right panel). 
found exclusively in C57BL/6 mice (K. E. Stein, C. Bona, R. Lieberman, C. C. Chien, 
and W. E. Paul. Unpublished observations.). 
There are several mechanisms by which regulatory genes could influence antibody 
expression.  A  trivial explanation  is  that  the  C57BL  background  contributes  a  gene 
that results in an increased amount of anti-In antibodies in mice of the Igh a type, thus 
allowing spectrotypes normally present in BALB/c mice in nondetectable amounts to 
now  be  detected.  Our  quantitative  data  on  the  amount  of  anti-In  antibodies  as 
detected by HA  (14)  or by radioimmunoassay (K. E.  Stein, C.  Bona, R.  Lieberman, 
C. C. Chien, and W. E.  Paul. Unpublished observations.) as well as the radioimmu- 
noassay data of Slack et al.  (15)  indicate that  there are no significant differences in 
the  total amount  of anti-In  antibodies in  BALB/c,  B.C8,  CXBJ,  and  CXBG  mice. 
We  do  not  believe, therefore,  that  the  IEF differences observed here  are  entirely a 
result of quantitative differences in the anti-In antibodies. 
A  second  explanation  for  the  observed  differences  in  spectrotype  is  that  C57BL 
mice contribute  a  different  light chain  to  the  anti-In  antibodies than  is present  in 
BALB/c mice and that this results in new clonotype expression. Because there are no 
markers to distinguish BALB/c and C57BL  light chains, this explanation cannot  be 
directly tested.  We  do  not  favor  this  explanation,  however,  because  we  know  that 
BALB/c mice can produce heterogeneous  anti-In antibodies if they are immunized 
with stronger immunogens than soluble polysaccharides, such as In-BA or In-KLH in 
CFA (Fig. 3). We conclude from these studies that  BALB/c mice possess light chains 
that  can  participate in  the  formation  of antibodies that  express heterogeneous  IEF 
patterns. STEIN, BONA, LIEBERMAN,  CHIEN, AND PAUL  1101 
A third explanation for the observed regulation is that the increased diversity seen 
upon introduction of Sr-1 or other C57BL regulatory genes into BALB/c mice results 
from the expression of additional IgG subclasses and perhaps greater switching from 
IgM to IgG. Our preliminary data suggest that whereas the IgG anti-In antibodies in 
BALB/c mice are all of the IgG1 subclass,  B.C8 mice produce anti-In antibodies of 
the IgG2a, IgG2b, and IgG3 subclasses in addition to IgG1. We are currently extending 
these studies to determine if regulation of Ig class expression is indeed the mechanism 
through which Sr-1 and other regulatory genes exert their effect and if this is mediated 
via the T  cell. 
Summary 
The  antibody response  to  the  inulin  [(In), fl-(2 ~  1)  fructosan]  determinant  of 
bacterial  levan  [(BL),  a  fl-(2  ~  6)  polyfructosan that  contains /~-(2 ~  1)  branch 
points]  requires  the presence of the a  haplotype of the Igh  gene complex.  BALB/c 
(Igh a) mice immunized with BL produce IgG anti-In antibodies of a single spectrotype 
by isoelectric focusing analysis. C57BL/6 mice, which possess  the b haplotype of the 
Igh gene complex and which fail to produce anti-In antibodies, nevertheless possess  a 
gene, spectrotype regulation gene 1 (Sr-1), that regulates the isoelectric focusing (IEF) 
pattern  of anti-In antibodies in  mice of the a  haplotype. Thus,  the IEF patterns of 
anti-In antibodies of (BALB/c ×  C57BL/6)FI mice and of B.C8 mice (C57BL/Ka • 
Igh-C ~)  are  considerably more complex  than  those  of BALB/c.  Backcross analysis 
indicates  that  Sr-1  is  not  linked  to  the  Igh  complex,  the  major  histocompatibility 
complex, or to the genes that code for coat color. Studies of the heterogeneity of anti- 
In  antibodies  in  recombinant  inbred  lines  and  their  progeny  from  matings  to 
BALB/c and  C.B20  (BALB/c  •  Igh-C b)  suggest  the  existence  of other  regulatory 
genes. 
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